Search Results - "Quiralte, Miguel"

Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution by Garcia-Donas, Jesus, Martínez-Urbistondo, Diego, Velázquez Kennedy, Kyra, Villares, Paula, Barquin, Arántzazu, Dominguez, Andrea, Rodriguez-Moreno, Juan Francisco, Caro, Elena, Suarez Del Villar, Rafael, Nistal-Villan, Estanislao, Yagüe, Monica, Ortiz, Maria, Barba, Maria, Ruiz-Llorente, Sergio, Quiralte, Miguel, Zanin, Massimiliano, Rodríguez, Cristina, Navarro, Paloma, Berraondo, Pedro, Madurga, Rodrigo

“…Managing the inflammatory response to SARS-Cov-2 could prevent respiratory insufficiency. Cytokine profiles could identify cases at risk of severe disease. We…”
Get full text

Impact of the Identification of Nonhuman Genetic Signatures in the Diagnosis and Management of Carcinoma of Unknown Primary by Barquín García, Arantzazu, Palacios-Zambrano, Sara, Lozano Alarcón, Felipe, Paumard-Hernández, Beatriz, Quiralte Pulido, Miguel, Navarro, Paloma, Rodríguez, Laura, Salas Villar, Isabel, García-Donas, Jesús

“…This report presents the case of a 62-year-old woman who was diagnosed in 1999 with stage I cervical carcinoma treated by surgical resection. In 2021, she…”
Get more information

Prognostic Value and Clinical Significance of FGFR Genomic Alterations (GAs) in Metastatic Urothelial Cancer Patients by Sevillano Fernández, Elena, Madurga de Lacalle, Rodrigo, Rodriguez Moreno, Juan Francisco, Barquín García, Arantzazu, Yagüe Fernández, Mónica, Navarro Alcaraz, Paloma, Barba Llacer, María, Quiralte Pulido, Miguel, García-Donás Jiménez, Jesús

“…Fibroblast growth factor receptor (FGFR) genomic alterations (GAs) represent an actionable target, key to the pathogenesis of some urothelial cancers (UCs)…”
Get full text

Prognostic impact of fibroblast growth factor receptor (FGFR) genomic alterations and outcomes in patients with metastatic urothelial by Sevillano, Elena, Madurga, Rodrigo, Rodriguez Moreno, Juan Francisco, Barquin, Arantzazu, Yagüe, Monica, Navarro, Paloma, Barba, María, Quiralte, Miguel, García-Donas, Jesús

“…Abstract only 537 Background: FGFR mutations/translocations are druggable targets in metastatic urothelial cancer (mUC). However, the prognostic effect of…”
Get full text

Proteomic profiling of peritoneal fluid-derived exosomes as a tool for the identification of prognostic markers in advanced ovarian carcinomas by Quiralte, Miguel, Barquin, Arantzazu, Yagüe, Monica, Navarro, Paloma, Sevillano, Elena, Rodriguez-Moreno, Juan Francisco, Balarezo, Alejandra, Peinado, Héctor, Izquierdo, Elena, Millan, Carlos, Lopez, Irene, Ruiz-Llorente, Sergio, García-Donas, Jesús

“…e17561 Background: Exosomes have been involved in tumor progression and development of therapeutic resistances in several malignancies. This subtype of…”
Get full text

Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer by Quiralte, Miguel, Barquín, Arantzazu, Yagüe-Fernández, Mónica, Navarro, Paloma, Grazioso, Tatiana P, Sevillano-Fernández, Elena, Rodriguez-Moreno, Juan F, Balarezo-Saldivar, Alejandra, Peinado, Héctor, Izquierdo, Elena, Millán, Carlos, López-Carrasco, Irene, Prieto, Mario, Madurga, Rodrigo, Fernández-Miranda, Ismael, Ruiz-Llorente, Sergio, García-Donas, Jesús

“…Cancer-derived small extracellular vesicles (sEVs) are capable of modifying the tumor microenvironment and promoting tumor progression. Ovarian cancer (OvCa)…”
Get full text

Abstract 3223: Prospective study for the assessment of exosomes in ascitic fluid as prognostic markers in patients with advanced ovarian cancer by Quiralte, Miguel, Barquin, Arantzazu, Sevillano, Elena, Navarro, Paloma, Yagüe, Monica, Barba, Maria, Rodriguez-Moreno, Juan F., Balarezo, Alejandra, Peinado, Héctor, Izquierdo, Elena, García-Donas, Jesús, Ruiz-Llorente, Sergio

“…Abstract Background: Exosomes have been involved in tumor progression and the development of therapeutic resistances in several malignancies. These…”
Get full text